-
Behavioural scienceAdherence and persistence refines
Semaglutide for obesity: two-thirds of new Wegovy users stopped within a year
Of 34,309 Clalit members without diabetes starting Wegovy in 2025, 67.6% had stopped by one year.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Type 2 diabetes being diagnosed at older ages in Israel, and with more co-morbidities
Median age at diagnosis rose from 63.0 to 66.7 years between 2005-2008 and 2020-2023 in one Israeli health system.
Peer-reviewed -
Data, models and systemsAI in medicine refines
Three Holter ECG measures with age predicted five-year mortality in Israeli adults
A random forest combining atrial fibrillation burden, premature ventricular contraction burden, T-wave alternans and age reached an AUROC of 0.79 for five-year mortality in 54,395 Israeli primary care patients.
Peer-reviewed
